drugset / Trial / NCT01422135

Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females

NCT01422135

Phase 1 Completed 24 enrolled Agile Therapeutics
RandomizedCrossoverOpen-labelBasic science

Summary

This is a pharmacokinetics and safety study over 3 weekly applications.

Timeline

Start
2011-02
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AG200-15 Unknown Other

Indications

No indication recorded.